There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...

PHILADELPHIA (WPVI) -- The FDA is investigating an alarming finding on a promising cancer therapy invented at Penn Medicine. It's being linked to rare, secondary cancers. The agency said it received ...

"ALA-CART improves the ability of CAR-T cells to detect and attack resistant cancer cells more effectively. This could lead to longer lasting results, even when other treatments have failed," said M.

The U.S. Food and Drug Administration advisory committee unanimously recommended the agency approve a unique “living drug” approach to treat a common form of leukemia in children and young adults, ...

Lyell Immunopharma has acquired worldwide rights from ICT to LYL273, an advanced CAR T-cell candidate for metastatic ...

Looking to build a new laboratory or expand your existing facility. Talk to your Formaspace Design Consultant about our custom lab furniture solutions, built in the USA, at our Austin, Texas, factory ...

Axi-cel demonstrated superior progression-free survival compared to tisa-cel, despite a higher toxicity profile, including increased neurotoxicity and cytokine release syndrome. The CAR-HEMATOTOX ...

Prime Minister Narendra Modi gifted three path-breaking innovations, including CART-T Cell Therapy, India''s first indigemous cancer cell therapy developed by Indian Innovators with the support of the ...

Caribou Biosciences (NASDAQ:CRBU) stock tumbled 30% Monday amid the release of Phase 1 data from its ANTLER study for the company’s CART-T cell therapy CB-010. The company said in a statement released ...